Xenon Pharmaceuticals (XENE) Posts Q1 Loss of $0.30/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. DOX
4. AMGN
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Xenon Pharmaceuticals (XENE) Posts Q1 Loss of $0.30/Share

Xenon Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update

May 12, 2015 4:00 PM EDT

Continued Pipeline Progress in Partnered and Proprietary Programs

Conference Call/Webcast Today at 4:30 p.m. Eastern Time

BURNABY, British Columbia, May 12, 2015 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a clinical-stage biopharmaceutical company, today reported its financial results for the quarter ended March 31, 2015 and provided a corporate update.

Dr. Simon Pimstone, Xenon's President and Chief Executive Officer, said, "We continue to make good progress towards our goal of advancing a diversified pipeline of partnered and proprietary programs. In our... More